Commonwealth Equity Services’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-774
Closed -$215K 3410
2020
Q4
$215K Sell
774
-2,183
-74% -$809K ﹤0.01% 2857
2020
Q3
$1.21M Buy
2,957
+2,395
+426% +$1.23M ﹤0.01% 1384
2020
Q2
$326K Buy
562
+101
+22% +$46.1K ﹤0.01% 2215
2020
Q1
$105K Buy
+461
New +$79.9K ﹤0.01% 2570

Other funds holding CODX

Commonwealth Equity Services's CODX Position: Q1 2021 in Review

Commonwealth Equity Services sold out of Co-Diagnostics (CODX) in Q1 2021, closing a stake of 774 shares — an estimated $215K sold.

Commonwealth Equity Services first reported a position in CODX in Q1 2020 and held it in 4 quarters. The position peaked at $1.21M in Q3 2020. 95 funds tracked by Wall St. Rank hold CODX as of Q1 2021.

  • Commonwealth Equity Services reported no remaining Co-Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 774 Co-Diagnostics shares in Q1 2021, an estimated $215K.
  • Commonwealth Equity Services first reported a position in Co-Diagnostics in Q1 2020 and held it in 4 quarters.
  • Commonwealth Equity Services's Co-Diagnostics position peaked at $1.21M in Q3 2020.
  • 95 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2021.

Based on Commonwealth Equity Services's 13F filing for Q1 2021, filed 4 May 2021.